BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7986305)

  • 21. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
    Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
    Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherogenic factors in diabetes: the role of lipoprotein metabolism.
    Crepaldi G; Manzato E
    Postgrad Med J; 1988; 64 Suppl 3():10-2. PubMed ID: 3074293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus.
    Schneider J; Erren T; Zöfel P; Kaffarnik H
    Atherosclerosis; 1990 May; 82(1-2):97-103. PubMed ID: 2193640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperinsulinaemia and hypertriglyceridaemia.
    Steiner G
    J Intern Med Suppl; 1994; 736():23-6. PubMed ID: 7986304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of apoB-containing lipoprotein families in NIDDM.
    Alaupovic P; Bard JM; Tavella M; Shafer D
    Diabetes; 1992 Oct; 41 Suppl 2():18-25. PubMed ID: 1526331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of diabetic dyslipidaemia: where are we?
    Vergès B
    Diabetologia; 2015 May; 58(5):886-99. PubMed ID: 25725623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of various therapies on hyperlipidemia in diabetes mellitus.
    Calvert GD; Jenkins A; Abbey M
    Horm Metab Res Suppl; 1985; 15():94-8. PubMed ID: 3865889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus.
    Sutherland WH; Walker RJ; Lewis-Barned NJ; Pratt H; Tillman HC
    Clin Chim Acta; 1994 Nov; 231(1):29-38. PubMed ID: 7704946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and lipoproteins in patients with type 2 diabetes.
    Krauss RM
    Diabetes Care; 2004 Jun; 27(6):1496-504. PubMed ID: 15161808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The phenotypic characteristics and incidence of dyslipoproteinemias in diabetic patients].
    Kiriakov A; Koev D; Kavrykova Iu; Dimova Ia; Ovcharova N; Taneva T; Tinterova Z; Borisova A; Tsoneva G
    Probl Endokrinol (Mosk); 1990; 36(6):25-9. PubMed ID: 2087461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis.
    Barakat HA; Carpenter JW; McLendon VD; Khazanie P; Leggett N; Heath J; Marks R
    Diabetes; 1990 Dec; 39(12):1527-33. PubMed ID: 2245877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperlipidemia during diabetes mellitus. Recent developments].
    Guerci B; Ziegler O; Drouin P
    Presse Med; 1994 Jan; 23(2):82-8. PubMed ID: 8140078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence.
    Pyörälä K; Steiner G
    Ann Med; 1996 Aug; 28(4):357-62. PubMed ID: 8862691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipoproteinemia and diabetes mellitus].
    Růzek V
    Vnitr Lek; 1992 Jul; 38(7):715-20. PubMed ID: 1413578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
    Feingold KR; Grunfeld C; Pang M; Doerrler W; Krauss RM
    Arterioscler Thromb; 1992 Dec; 12(12):1496-502. PubMed ID: 1450181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus.
    Laakso M
    Ann Med; 1996 Aug; 28(4):341-5. PubMed ID: 8862689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid and lipoprotein abnormalities in non-insulin dependent diabetics (NIDDM).
    Nitiyanant W; Komoltri C; Ploybutr S; Vannasaeng S; Vichayanrat A; Piraphatdist T
    J Med Assoc Thai; 1987 Mar; 70 Suppl 2():204-8. PubMed ID: 3598433
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology of Diabetic Dyslipidaemia.
    Filippatos T; Tsimihodimos V; Pappa E; Elisaf M
    Curr Vasc Pharmacol; 2017; 15(6):566-575. PubMed ID: 28155609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relative concentration of VLDL C-apolipoproteins in the hyperlipoproteinaemia of haemodialysis-treated chronic renal failure (author's transl)].
    Dewailly P; Dedonder E; Fruchart JC; Sezille G; Jaillard J
    Diabete Metab; 1980 Mar; 6(1):13-6. PubMed ID: 7371894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.
    James RW; Pometta D
    Diabetologia; 1991 Apr; 34(4):246-52. PubMed ID: 2065858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.